NDC Package 17856-0672-4 Ondansetron

Ondansetron Hydrochloride Solution Oral - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
17856-0672-4
Package Description:
72 CUP, UNIT-DOSE in 1 CASE / 5 mL in 1 CUP, UNIT-DOSE
Product Code:
Proprietary Name:
Ondansetron
Non-Proprietary Name:
Ondansetron Hydrochloride
Substance Name:
Ondansetron Hydrochloride
Usage Information:
Ondansetron oral solution is indicated for the prevention of nausea and vomiting associated with:highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m 2initial and repeat courses of moderately emetogenic cancer chemotherapyradiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomenOndansetron oral solution is also indicated for the prevention of postoperative nausea and/or vomiting.
11-Digit NDC Billing Format:
17856067204
NDC to RxNorm Crosswalk:
Product Type:
Human Prescription Drug
Labeler Name:
Atlantic Biologics Corp.
Dosage Form:
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Administration Route(s):
Oral - Administration to or by way of the mouth.
Sample Package:
No
FDA Application Number:
ANDA078776
Marketing Category:
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date:
11-28-2007
Listing Expiration Date:
12-31-2026
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Other Product Packages

The following packages are also available for this product:

NDC Package CodePackage Description
17856-0672-160 SYRINGE in 1 CASE / 2.5 mL in 1 SYRINGE
17856-0672-2120 SYRINGE in 1 CASE / 2.5 mL in 1 SYRINGE
17856-0672-3120 SYRINGE in 1 CASE / 2.5 mL in 1 SYRINGE

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 17856-0672-4?

The NDC Packaged Code 17856-0672-4 is assigned to a package of 72 cup, unit-dose in 1 case / 5 ml in 1 cup, unit-dose of Ondansetron, a human prescription drug labeled by Atlantic Biologics Corp.. The product's dosage form is solution and is administered via oral form.

Is NDC 17856-0672 included in the NDC Directory?

Yes, Ondansetron with product code 17856-0672 is active and included in the NDC Directory. The product was first marketed by Atlantic Biologics Corp. on November 28, 2007 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 17856-0672-4?

The 11-digit format is 17856067204. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-4-117856-0672-45-4-217856-0672-04